Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10875-021-00997-6 http://scihub22266oqcxt.onion/10.1007/s10875-021-00997-6 33725211!7962425!33725211     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Immunol 2021 ; 41 (5): 906-913 Nephropedia Template TP {{tp|p=33725211|t=2021. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses |pdf=|usr=}}{{33725211}} gab.com Text Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses JO: J Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33725211 #FOAvip In order to properly understand the spread of SARS-CoV-2 infection and development of humoral immunity, researchers have evaluated the presence of serum antibodies of people worldwide experiencing the pandemic. These studies rely on the use of recombinant proteins from the viral genome in order to identify serum antibodies that recognize SARS-CoV-2 epitopes. Here, we discuss the cross-reactivity potential of SARS-CoV-2 antibodies with the full spike proteins of four other betacoronaviruses that cause disease in humans, MERS-CoV, SARS-CoV, HCoV-OC43, and HCoV-HKU1. Using enzyme-linked immunosorbent assays (ELISAs), we detected the potential cross-reactivity of antibodies against SARS-CoV-2 towards the four other coronaviruses, with the strongest cross-recognition between SARS-CoV-2 and SARS /MERS-CoV antibodies, as expected based on sequence homology of their respective spike proteins. Further analysis of cross-reactivity could provide informative data that could lead to intelligently designed pan-coronavirus therapeutics or vaccines. Twit Text FOAVip Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses ????J Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33725211 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33725211 #FOAvip English Wikipedia <ref>{{Cite pmid|33725211}}</ref> Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses #MMPMID33725211 Hicks J; Klumpp-Thomas C; Kalish H; Shunmugavel A; Mehalko J; Denson JP; Snead KR; Drew M; Corbett KS; Graham BS; Hall MD; Memoli MJ; Esposito D; Sadtler K J Clin Immunol 2021[Jul]; 41 (5): 906-913 PMID33725211show ga In order to properly understand the spread of SARS-CoV-2 infection and development of humoral immunity, researchers have evaluated the presence of serum antibodies of people worldwide experiencing the pandemic. These studies rely on the use of recombinant proteins from the viral genome in order to identify serum antibodies that recognize SARS-CoV-2 epitopes. Here, we discuss the cross-reactivity potential of SARS-CoV-2 antibodies with the full spike proteins of four other betacoronaviruses that cause disease in humans, MERS-CoV, SARS-CoV, HCoV-OC43, and HCoV-HKU1. Using enzyme-linked immunosorbent assays (ELISAs), we detected the potential cross-reactivity of antibodies against SARS-CoV-2 towards the four other coronaviruses, with the strongest cross-recognition between SARS-CoV-2 and SARS /MERS-CoV antibodies, as expected based on sequence homology of their respective spike proteins. Further analysis of cross-reactivity could provide informative data that could lead to intelligently designed pan-coronavirus therapeutics or vaccines. |Adolescent[MESH] |Adult[MESH] |Antibodies, Viral/blood[MESH] |Betacoronavirus/*immunology[MESH] |Cross Reactions[MESH] |Enzyme-Linked Immunosorbent Assay[MESH] |Humans[MESH] |Middle Aged[MESH] |SARS-CoV-2/*immunology[MESH] |Sequence Homology, Amino Acid[MESH] |Spike Glycoprotein, Coronavirus/immunology[MESH]Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Be(epmc).pdf DeepDyve Pubget Overpricing